Table 2. Residual tumor cases in re-TURBT according to initial pathology.
Parameter | No residual tumor (n = 91) | Residual tumor (n = 107) | P |
---|---|---|---|
Gender (Female) | 13 (14.3%) | 21 (19.6%) | 0.211 |
Age | 0.052 | ||
<60 | 34 (37.4%) | 42 (39.3%) | |
61–70 | 37 (40.7%) | 28 (26.2%) | |
70< | 20 (22.0%) | 37 (34.6%) | |
Previous UUTa History | 7 (7.7%) | 6 (5.6%) | 0.379 |
Prev. Recur History | 4 (4.4%) | 10 (9.3%) | 0.394 |
T stage | 0.841 | ||
Ta | 13 (14.3%) | 17 (15.9%) | |
T1 | 76 (83.5%) | 85 (79.4%) | |
CIS | 2 (2.2%) | 5 (4.7%) | |
Grade | 0.017 | ||
Unknown | 0(0%) | 0 (0%) | |
Low grade | 18 (19.8%) | 9 (8.4%) | |
High grade | 73 (80.2%) | 98 (91.6%) | |
Concomitant CIS | 5 (5.5%) | 19 (17.8%) | 0.007 |
Size | 0.089 | ||
≥3Cm | 21 (23.1%) | 35 (32.7%) | |
Tumor Number | 0.007 | ||
1 | 53 (58.2%) | 39 (31.2%) | |
2–7 | 31 (34.1%) | 51 (47.7%) | |
7< | 7 (7.7%) | 17 (15.9%) | |
CRPb | 76.78±18.91 | 69.37±16.30 | 0.601 |
aUUT = Upper urinary tract tumor
bCRP = C-reactive protein